- Home
- RVMD vs ESS Comparison
RVMD vs ESS Comparison
Compare RVMD & ESS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVMD | ESS |
|---|---|---|
| Founded | 2014 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2B | 16.3B |
| IPO Year | 2020 | 1994 |
Fundamental Metrics
Financial Performance| Metric | RVMD | ESS |
|---|---|---|
| Price | $96.84 | $252.98 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 16 | 16 |
| Target Price | $102.63 | ★ $286.23 |
| AVG Volume (30 Days) | ★ 5.7M | 576.2K |
| Earning Date | 02-25-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 4.15% |
| EPS Growth | N/A | ★ 53.64 |
| EPS | N/A | ★ 13.15 |
| Revenue | N/A | ★ $1,916,711,000.00 |
| Revenue This Year | N/A | $3.91 |
| Revenue Next Year | $740.40 | $3.54 |
| P/E Ratio | ★ N/A | $18.83 |
| Revenue Growth | N/A | ★ 9.37 |
| 52 Week Low | $29.17 | $243.25 |
| 52 Week High | $124.49 | $316.29 |
Technical Indicators
Market Signals| Indicator | RVMD | ESS |
|---|---|---|
| Relative Strength Index (RSI) | 45.96 | 49.48 |
| Support Level | $96.72 | $245.70 |
| Resistance Level | $98.64 | $252.96 |
| Average True Range (ATR) | 3.97 | 4.90 |
| MACD | -3.23 | -0.14 |
| Stochastic Oscillator | 12.07 | 56.23 |
Price Performance
Historical ComparisonAbout RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
About ESS Essex Property Trust Inc.
Essex Property Trust owns a portfolio of 258 apartment communities with over 62,000 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.